NEJM at ESMO - Zolbetuximab in Gastric or Gastroesophageal Junction Adenocarcinoma No … ← NEJM at ESMO - Ponsegromab in Cancer Cachexia NEJM at ESMO - Phase 3 Trial of Cabozantinib in Advanced Neuroendocrine Tumors →